CEO @ Vyro Biotherapeutics, a biotech company advancing the development of oncolytic viral immunotherapy based on the oZIKV platform for the treatment of aggressive brain tumors.
Invited by: Carlos Eduardo Curioni
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
July 24, 2023 | 64 | +1 | +1.6% |
October 31, 2022 | 63 | +1 | +1.7% |
March 29, 2022 | 62 | +1 | +1.7% |
January 30, 2022 | 61 | +1 | +1.7% |
December 23, 2021 | 60 | +2 | +3.5% |
October 08, 2021 | 58 | +2 | +3.6% |
August 27, 2021 | 56 | +7 | +14.3% |